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Abstract
Background: Primary CNS vasculitis (PCNSV) can be
diagnosed using cerebral angiography or histopa-
thology combined with clinical features. The original
diagnostic criteria, which weigh each test equally,
have not been validated. Limited sensitivity and
specificity for biopsy and angiography are recog-
nized. We systematically reviewed results of diag-
nostic tests performed in patients with an ultimate
diagnosis of PCNSV. Methods: We searched the
OVID Medline database and bibliographies for origi-
nal cases of PCNSV. We recorded demographics, di-
agnostic tests used, and assessed agreement
between angiography and biopsy when both tests were performed. We also recorded MRI
and CSF results. Results: We found 701 original cases with PCNSV diagnosed with angiog-
raphy or pathology. A total of 269 patients (38.4%) had both cerebral angiography and his-
topathologic testing (biopsy/postmortem). Classic angiographic features of vasculitis were
associated with pathologic confirmation in just 32 patients (4.6%). Seventy-four patients
(10.6%) with any abnormality on angiography had a normal biopsy, and 99 patients
(14.1%) with abnormal biopsies had normal angiography. Brain MRI was abnormal in
505/541 patients (93.3%) and CSF was abnormal in 360/484 patients (74.4%). Increas-
ing use of angiography and decreasing histopathologic testing were found over time.
Conclusions: Cerebral angiography and pathologic tissue examination were undertaken in
a minority of published cases with a diagnosis of PCNSV. When both diagnostic tests were
performed, disagreement between them was more than 5 times more likely than agreement.
Diagnostic criteria for PCNSV may require revision to classify the clinical, pathologic, and
radiologic features of this condition more accurately. Neurol Clin Pract 2017;7:1–10
P
rimary CNS vasculitis (PCNSV) is a rare inflammatory condition of unknown etiol-
ogy that may be disabling or potentially fatal.1 It remains a poorly understood
disorder and numerous different terms have been used to describe what is regarded,
perhaps incorrectly, as a single clinical entity, including cerebral vasculitis, primary
angiitis of the CNS, isolated granulomatous angiitis of the CNS, granulomatous angiitis,
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noninfectious angiitis, and benign angiopathy of the CNS. Diagnostic criteria were proposed
in 1988 and diagnosis requires a combination of clinical features of acquired CNS dysfunc-
tion, presence of typical pathologic or cerebral angiographic abnormalities, and lack of an
alternative unifying explanation.2 Earlier cases were typically diagnosed at postmortem, highlight-
ing the potentially serious nature of PCNSV, but noninvasive testing is now more easily acces-
sible and more benign cases with good outcomes are also recognized. Patients with suspected
PCNSV are typically treated aggressively with steroids or other immunosuppressant therapies,
which have associated risks,3 but to date no randomized clinical trials of therapies for PCNSV
have been undertaken. Proposals for multicenter collaboration to identify predictors of poor
outcome have been published, but results from these collaborations are not yet reported.4
Clinical, imaging, and angiographic mimics for PCNSV exist, several of which have been
described only in the recent past, or are contingent on recent imaging developments, adding
to the difficulty in interpreting historical data. One notable mimic is reversible cerebral vaso-
constriction syndrome (RCVS), which may have similar angiographic changes.5 Presentation
with thunderclap headache and resolution of angiographic changes over time suggests RCVS
rather than PCNSV. However, differentiating between angiographic changes due to different
conditions may be difficult early after clinical presentation. In addition, clinical features
overlap, leading to potential difficulties in clinical management when considering the need
for immunosuppressive therapy. Furthermore, diagnostic criteria for PCNSV remain unvali-
dated. It is also not clear to what extent angiographic changes reported in cases of PCNSV
correlate with pathologically confirmed cases. We hypothesized that if both tests (cerebral
angiography and pathologic assessment of brain tissue) contribute to the diagnosis of PCNSV
equally, as is suggested in the diagnostic criteria, then when performed together, both angi-
ography and brain pathology from either biopsy or postmortem would often be abnormal in
cases of PCNSV. We undertook a systematic review of the published literature on PCNSV.
We sought to examine and compare diagnostic test results of pathology and cerebral angi-
ography and to investigate the use of other tests including brain MRI and CSF analysis in
published cases on PCNSV.
METHODS
Protocol
The study was performed in line with the recommendations of the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses.6
Search strategy and selection criteria
We used a comprehensive search strategy of the OVID Medline database on September 29,
2015, for articles that met our predefined eligibility criteria. We searched the reference lists
of published cases and review articles on PCNSV for additional articles not detected by the
original search strategy. The search strategy is shown in appendix e-1 at Neurology.org/cp.
Articles were included if they reported on any case of PCNSV in an adult population
(defined as age $16 years) and were published in English. Diagnostic terms considered
synonymous with PCNSV included cerebral angiitis, cerebral vasculitis, CNS vasculitis,
granulomatous angiitis of the nervous system, primary angiitis of the CNS, isolated angiitis
of the CNS, cerebral arteritis, intracranial vasculitis, idiopathic angiitis of the CNS, or
noninfectious angiitis of the CNS. If multiple publications from the same patient cohort
were found, we reviewed the most recent or largest cohort publication to prevent dupli-
cation of results from individual patients. Exclusion criteria were cases with systemic forms
of vasculitis (i.e., vasculitis affecting any organ beyond the CNS), temporal arteritis,
secondary cause for CNS vasculitis (e.g., sarcoidosis, lymphoma, Behçet disease, infection
associated arteritis), and pediatric cases (,16 years). If articles described a mixed popula-
tion of vasculitis, only those patients defined as having PCNSV (or other synonymous
term) were analyzed.
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Data collection
Data collection was performed independently by 2 reviewers (F.M. and M.O.M.). Recorded
data included number of cases of PCNSV, mean age, sex, use of proposed diagnostic criteria,
use of tissue biopsy, presence/absence of a pathologically confirmed diagnosis including post-
mortem, use of cerebral angiography, presence/absence of any angiographic abnormality,
presence/absence of classical angiographic appearances for CNS vasculitis (multifocal arterial
stenosis/ectasia in multiple vessels, sometimes referred to as a string of beads sign),7,8 use of
brain MRI, and brain MRI results (including presence of infarction, hemorrhage, T2/fluid-
attenuated inversion recovery–based hyperintensities, gadolinium-enhancing lesions, abnor-
malities in multiple territories). Use of lumbar puncture and presence/absence of CSF
abnormalities were documented when available. Abnormal CSF was defined as CSF protein
concentration .0.4 g/L, CSF leucocyte count .5 per mm3, or CSF reported as abnormal by
the author. Presence of spinal involvement and venous abnormalities in pathologically con-
firmed cases were also recorded. Clinical outcomes and treatments administered were not
included. Any differences in recorded data from reviewers were resolved by consensus after
further review of the relevant publications.
Analysis
Published cases of PCNSV were collected and amalgamated for descriptive purposes. Fre-
quency of investigations and diagnostic yields were measured.
RESULTS
A total of 633 articles were generated from the Medline literature search and an additional
129 articles were reviewed after searching bibliographies of published cases. After screening
and removal of articles not meeting the specified diagnostic criteria, a total of 127 original
articles were included.2,7–40,e1–e92 A flowchart of inclusion and exclusion of articles is shown
in figure 1.
A total of 914 patients were reported overall in these studies. A total of 213 individual cases
from these articles were excluded as they related to secondary CNS vasculitis or other diagnoses,
leaving a final cohort of 701 patients with PCNSV. The median number of patients included
per publication was 1 (interquartile range 1–5, range 1–163). The mean age from those
publications where demographics were reported was 45 (SD 14) years with a range from
19 to 96 years.e11,e38 Fifty-five percent of patients were female.
Biopsy and angiographic results are summarized in table 1. CNS biopsy was performed for 352
patients (50.2%) and confirmed PCNSV in 248 (35.4%). A total of 54 patients were diagnosed
at postmortem.2,8,9,40,e13,e20,e28,e32,e35,e38,e43–e46,e48,e50–e53,e55,e57,e58,e62–e65,e68,e69,e71,e73–e75,e85,e91,e93 Of those
with PCNSV confirmed at postmortem, 8 cases had a previously performed brain biopsy that
had not shown evidence for CNS vasculitis8,e35,e38,e48,e59,e71,e74,e93; however, only one of these
patients had brain MRI performed as part of a diagnostic workup prior to cerebral biopsye35
and the biopsy procedures were usually blind or needle biopsies.
Angiography was performed in 581/701 cases (82.9%), including catheter angiography in
538/701 (76.7%) and magnetic resonance angiography/CT angiography in 211/701 (30.1%).
Catheter angiography revealed the presence of any abnormality in 417/538 cases (77.5% of group,
59.5% of total cohort), and 322/538 (59.8% of group, 45.9% of total cohort) patients had a classic
angiographic appearance7,8 with multiple areas of stenosis or ectasia in multiple vessels.
Pathologic examination of CNS tissue combined with any form of angiography was per-
formed in 268/701 patients (38.2%) and CNS biopsy with catheter angiography was per-
formed in 232/701patients (33.1%). A total of 71/302 patients (23.5% of group, 10.1% of
total cohort) with PCNSV confirmed by pathologic examination also had an abnormal angio-
gram but only 32/302 patients (10.6% of group, 4.6% of total cohort) with pathologically con-
firmed PCNSV were reported with an angiogram that showed classical appearances associated
with PCNSV.7,8
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In 99 patients with pathologically confirmed vasculitis, cerebral angiography was normal
(14% of total cohort). In 74 patients (10.6% of total cohort), CNS pathology was normal
but angiography was classical for PCNSV. PCNSV was diagnosed despite both CNS pathology
examination and angiography being normal for 12 patients (1.7%).
The overall number of new cases published per decade has increased from 7 prior to the
1960s to 322 in the decade from 2010 onward. The proportion of cases diagnosed at postmor-
tem declined, over time, while the use of less invasive testing with angiography has increased
over the same time period. Changes in the frequency for use of different diagnostic tests for
PCNSV over time are shown in figure 2.
MRI brain and CSF findings are summarized in table 2. A total of 541 patients (77.2%)
had brain MRI performed, which was abnormal in 505 (93.3%) and normal in 36 (6.7%).
Abnormalities reported on MRI brain included infarction (n 5 234 [43.3%]), white matter
hyperintensities (n 5 203 [37.5%]), gadolinium-enhancing lesions (n 5 150 [27.7%]),
hemorrhagic lesions (n 5 76 [14.0%]), and multiple territory involvement (n 5 223
[41.2%]). A total of 484 patients (69% of total cases) had lumbar puncture performed.
CSF results were abnormal in 360 (74.4%) and normal in 124 (25.6%). Ancillary test results
are shown in table 2.
PCNSV with spinal cord involvement was reported in 9 patients.22,23,e29,e39,e43,e57,e64,e75,e81
Venous involvement in pathologically confirmed cases was reported in 6 patients.e31,e50,e58,e63,e69,e91
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow
diagram
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DISCUSSION
This systematic review reveals substantial heterogeneity in the use of diagnostic tests performed
in patients given a final diagnosis of PCNSV. Our analysis shows that a wide range of diagnostic
tests are used when diagnosing PCNSV, but both definitive tests (cerebral angiography and tis-
sue histopathologic examination) were performed together in only a minority of patients
(34%). Furthermore, when cerebral angiography and brain biopsy/postmortem are undertaken
in the same patient, they give conflicting results more frequently than agreement. Only 32
patients (4.6%) had a classic angiographic appearance reported in combination with a patholog-
ically confirmed vasculitis.7,8 When PCNSV was confirmed pathologically, cerebral angiog-
raphy was approximately 3 times more likely to be normal than abnormal. Conversely, when
angiography did suggest PCNSV, a cerebral biopsy was more than twice as likely to be normal
than to show changes in keeping with vasculitis.
The reasons for conflicting results between diagnostic tests in PCNSV are likely to be mul-
tiple. One reason for negative biopsy results in PCNSV confirmed angiographically is sampling
Table 1 Frequency of angiography, biopsy, and postmortem in published cases of primary
CNS vasculitis (PCNSV)
Test No.
% of all
PCNSV
% of total
tested
No. of original PCNSV 701 100
Any pathologic diagnosis made 301 42.9 74.1a
Postmortem diagnosis 54 7.7
Biopsy performed 352 50.2
Biopsy positive 248 35.4 70.5
Biopsy negative 104 14.8 29.5
Postmortem PCNSV with previous normal biopsy 8 1.1
Postmortem PCNSV with previous biopsy
also showing PCNSV
1 0.2 8.3
Any angiogram performed 581 82.9
Biopsy and any angiogram performed 248 35.4
Biopsy and any angiogram both abnormal 71 10.1 28.6
Biopsy abnormal, angiogram normal 91 13.0 33.7
Biopsy normal, angiogram abnormal 74 10.6 29.8
Biopsy normal, angiogram normal 12 1.7 4.8
Biopsy abnormal with classic angiographic
appearanceb
26 3.7 11.2
Any pathologic diagnosis with classic angiographic
appearances
32 4.6 11.9
aPercent of patients with any CNS pathological testing.
bShowing alternating areas of ectasia or stenosis in multiple areas within multiple cerebral vessels.
This systematic review reveals substantial
heterogeneity in the use of diagnostic tests
performed in patients given a final diagnosis of
PCNSV.
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error due to the patchy anatomical nature of the condition itself with skip lesions.e15,e48 The fact
that biopsy results were negative in some patients who went on to have PCNSV confirmed at
postmortem confirms that false-negative biopsies occur. However, these cases were reported
predominantly in patients who did not have other imaging such as brain MRI as part of their
clinical investigations prior to biopsy. Neuroimaging would now be considered routine and
could help guide sampling of affected tissue to increase diagnostic yield from biopsy. When
no accessible tissue is available for biopsy, biopsy of nondominant temporal lobe leptome-
ninges may be considered. The false-negative rate for cerebral biopsy after obtaining brain
MRI when postmortem is used as a gold standard is not known. Negative biopsy results in
the context of abnormal cerebral angiography have usually been considered as false-negative
biopsies in patients who went on to be treated as having PCNSV.11 However, the very low
agreement between angiography and histopathology in PCNSV is worthy of further attention
and may reflect different vessel size involvement in angiogram-positive and angiogram-
negative cases. Lack of autopsy reporting following a positive biopsy is an inevitable publi-
cation bias compounded by declines in autopsy rates.e94
The original diagnostic criteria for PCNSV give equal weight to angiography and histopath-
ologic examination.2 Some authors have suggested more recently that pathologic examination
should be a gold standard for diagnosing definite cases of PCNSV3 while others have high-
lighted the importance of biopsy to look for an alternative diagnosis in patients initially
suspected of having PCNSV.e15 If pathologic confirmation is considered the reference stan-
dard for PCNSV,3 the data presented here suggest that angiography may be prone to giving
false-positive results. This is particularly important given the presence of known disorders
such as RCVS, which can have similar angiographic imaging appearances to PCNSV and for
Figure 2 Frequency of use of angiographic and tissue pathology testing in published cases
of primary CNS vasculitis (PCNSV) per decade
Our analyses suggest that biopsy and
angiography should not be considered as
equivalent tests given the lack of agreement.
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which radiologic features to reliably distinguish the disorders have yet to be confirmed.26
Angiographically diagnosed PCNSV with good outcomes (often after administration of cor-
ticosteroids)13,14 could potentially represent other more benign conditions like RCVSe95 or
posterior reversible encephalopathy syndrome in which the pathologic changes are not
known, but diagnostic criteria permit labeling such cases as PCNSV. Furthermore, negative
biopsy results in patients investigated for PCNSV have not, to our knowledge, been reported
as true negatives, with sampling error or inherent low sensitivity typically offered as the
explanation for a normal biopsy.
Tests of diagnostic accuracy may not always be compared to a reference standard for several
reasons, as missing reference data can be due to study design, clinical practice, and unfeasibility,
all of which may be relevant when considering a relatively uncommon condition of diverse clin-
ical presentations such as PCNSV.e96 However, our analysis shows that a proposed reference
standard such as pathologic examination is available in a proportion of patients and even then
angiography gives conflicting results when compared to this reference standard, possibly due
to limited specificity. Furthermore, when frequencies of diagnostic tests are shown over time
(figure 2), there is a shift towards less invasive testing with biopsy and in particular post-
mortem, and an increased use of angiography, which is more accessible. This is appropriate to
reduce unnecessary morbidity associated with biopsy and is consistent with similar neurologic
conditions such as cerebral amyloid angiopathy.e97 Our analyses suggest that biopsy and
angiography should not be considered as equivalent tests given the lack of agreement and
that further validation of imaging criteria for PCNSV is required against biopsy/postmortem
confirmed cases as well as defining features to distinguish PCNSV from RCVS.e95 Concerns
over safety of CNS biopsy are common and although complication rates from biopsy can vary
from low to moderate, the importance of biopsy is highlighted by the detection of PCNSV
and its mimics using histopathologic testing.e55,e98
Although MRI and CSF examination were not part of the proposed diagnostic criteria, they
are used frequently in the assessment of patients with PCNSV.9 Vessel wall contrast enhance-
ment on MRI has recently been reported as a potential imaging biomarker for PCNSV,e11 but
most parenchymal abnormalities seen on brain MRI are not specific for vasculitis and may be
seen in many other disorders. Our analysis shows that MRI brain is frequently abnormal in
patients with PCNSV, but that the reported changes vary among cases, and multiple different
imaging abnormalities are likely to be seen in various combinations. Apart from vessel wall
contrast enhancement, no other MRI feature has been proposed to show specific signs for
PCNSV. In addition, CSF results when available were usually abnormal in patients with
Table 2 CSF and MRI results in primary CNS vasculitis (PCNSV)
Test No. % of all PCNSV % of total tested
Lumbar puncture performed 484 69.0
CSF constituents abnormal 360 51.4 74.4
CSF constituents normal 124 17.7 25.6
MRI performed 541 77.2
MRI abnormal 505 72.0 93.3
MRI normal 36 5.1 6.7
MRI hemorrhage present 76 10.8 14.0
MRI enhancing lesions present 150 21.4 27.7
MRI T2/fluid-attenuated inversion recovery
white matter lesions present
203 29.0 37.5
MRI infarction present 234 33.4 43.3
MRI evidence of multiple territories involved 223 31.8 41.2
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reported PCNSV, but as with brain MRI are not specific for PCNSV. The fact that spinal
involvement has been pathologically confirmed on several occasions in PCNSV highlights the
possible anatomical extent of this condition, and suggests that other terms such as cerebral
vasculitis are misleading and should be avoided. Furthermore, the presence of venous abnor-
malities on biopsy and postmortem samples may point towards different forms of vasculitis,
which may inherently not have an arterial abnormality present on imaging or even on
pathology. The range of pathologic and anatomical changes reported emphasizes that PCNSV
remains poorly understood and heterogeneous, and international collaboration to form reg-
istries as a means of further study is overdue.
Our study has strengths and weaknesses. We collected information from all known cases
of PCNSV published in the English language from as early as 1922e91 to capture information
about diagnostic tests in the largest possible number of patients. PCNSV cases by their
nature are inevitably prone to publication bias, and the fact that only a minority had both
angiography and CNS pathologic testing performed in the same patient may reflect a pref-
erence for less invasive testing in clinical practice, which could further contribute to
publication bias. In addition, determining abnormalities in angiography from case reports
rather than review of original images has inherent drawbacks, but each publication was
reviewed with prespecified criteria by 2 reviewers independently to minimize bias. Lack of
consistently detailed clinical, radiologic, and treatment follow-up data are also a limitation.
Measuring the diagnostic accuracy of one test compared to another test using a validated
tool such as QUADASe99 was not undertaken because no agreed reference standard test for
PCNSV exists, a finding emphasized within the results. In addition, postmortem findings
were not systematically reported in such cases.
In order to determine more information about PCNSV and its mimics, use of more spe-
cific diagnostic criteria are required in order to prevent misclassification of other condi-
tions as PCNSV. Involvement of vessels with different calibers in different PCNSV
subtypes could be an explanation for poor agreement between tests, but it is unclear
how to accurately define these based on current criteria. In addition to devising new
and more specific diagnostic criteria, international collaboration using registries is required
to classify this condition more accurately and to compare specific clinical, laboratory, and
radiologic features against biopsy and postmortem.4 Although a rare condition, PCNSV is
often considered in clinical practice but mimics are relatively more common. In order to
tailor treatment appropriately, use of diagnostic criteria that define PCNSV more spe-
cifically should be used in the first instance3 (table 3).
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